CSIMarket
 


Syneos Health Inc   (SYNH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

SYNH's Net Cash Flow Growth by Quarter and Year

Syneos Health Inc 's Net Cash Flow results by quarter and year




SYNH Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -58.10 -16.06 23.28
III Quarter September - 64.11 -138.60 -94.13
II Quarter June -28.78 -13.16 -3.55 7.07
I Quarter March -0.95 12.68 -7.48 172.27
FY   -29.73 5.53 -165.69 108.49



SYNH Net Cash Flow second quarter 2023 Y/Y Growth Comment
Syneos Health Inc in the second quarter 2023 recorded net cash outflow of $ -28.78 millions.

According to the results reported in the second quarter 2023, Syneos Health Inc achieved the best Net Cash Flow growth in Medical Laboratories industry. While Syneos Health Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the second quarter 2023.




SYNH Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -32.5 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - 1298.07 %

Financial Statements
Syneos Health Inc 's second quarter 2023 Net Cash Flow $ -28.78 millions SYNH's Income Statement
Syneos Health Inc 's second quarter 2022 Net Cash Flow $ -13.16 millions Quarterly SYNH's Income Statement
New: More SYNH's historic Net Cash Flow Growth >>


SYNH Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -95.9 %
I Quarter March - - - 399.48 %
FY (Year on Year)   - - - 1298.07 %




Net Cash Flow second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Syneos Health Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SYNH's II. Quarter Q/Q Net Cash Flow Comment
Recent results of -28.78 millions by Syneos Health Inc appear even worse considering the -0.95 millions in the first quarter.

Within Medical Laboratories industry Syneos Health Inc achieved highest sequential Net Cash Flow growth. While Syneos Health Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SYNH's II. Quarter Q/Q Net Cash Flow Comment
Current net cash outflow of -28.78 millions by Syneos Health Inc look even more unfavourable if you take a look at -0.95 millions net cash outflow in the previous quarter.

Within Medical Laboratories industry Syneos Health Inc achieved highest sequential Net Cash Flow growth. While Syneos Health Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Syneos Health Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ -23.71 $ -8.10 $ 5.53 $ 47.57 $ -155.15
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - -88.38 % - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 485 # 517 # 351 # 0 # 0




Cumulative Net Cash Flow growth Comment


Syneos Health Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
1153.1 %
46.55 %
-252.74 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 84
S&P 500 # 485
Cumulative Net Cash Flow growth Comment


Syneos Health Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
1153.1 %
46.55 %
-252.74 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 84
S&P 500 # 485




Other Net Cash Flow Growth
Medical Laboratories Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
SYNH's Net Cash Flow Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for SYNH's Competitors
Net Cash Flow Growth for Syneos Health Inc 's Suppliers
Net Cash Flow Growth for SYNH's Customers

You may also want to know
SYNH's Annual Growth Rates SYNH's Profitability Ratios SYNH's Asset Turnover Ratio SYNH's Dividend Growth
SYNH's Roe SYNH's Valuation Ratios SYNH's Financial Strength Ratios SYNH's Dividend Payout Ratio
SYNH's Roa SYNH's Inventory Turnover Ratio SYNH's Growth Rates SYNH's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Jun 30 2023
Intuitive Surgical Inc 198.34%$ 198.337 millions
Therapeutic Solutions International Inc 188.95%$ 188.946 millions
Gri Bio Inc 157.88%$ 157.879 millions
Ensign Group Inc151.13%$ 151.134 millions
Pono Capital Two Inc 149.48%$ 149.483 millions
Ultragenyx Pharmaceutical Inc 147.94%$ 147.942 millions
Altitude Acquisition Corp 147.24%$ 147.244 millions
Hims and Hers Health Inc 147.03%$ 147.029 millions
Option Care Health Inc 145.34%$ 145.338 millions
Harmony Biosciences Holdings inc 140.59%$ 140.593 millions
International Stem Cell Corporation133.51%$ 133.511 millions
Pulse Biosciences Inc 119.09%$ 119.086 millions
Immuneering Corporation108.82%$ 108.815 millions
Synlogic Inc 106.19%$ 106.189 millions
Cumberland Pharmaceuticals Inc96.14%$ 96.142 millions
Tango Therapeutics Inc 88.32%$ 88.316 millions
The Greater Cannabis Company Inc 86.05%$ 86.054 millions
National Healthcare Corp80.35%$ 80.354 millions
Sensei Biotherapeutics Inc 79.71%$ 79.711 millions
Iradimed Corporation78.00%$ 78.000 millions
Mei Pharma Inc 74.89%$ 74.892 millions
Incyte Corporation73.65%$ 73.647 millions
Gilead Sciences Inc 73.36%$ 73.363 millions
Phathom Pharmaceuticals Inc 72.14%$ 72.139 millions
Sana Biotechnology Inc 70.23%$ 70.234 millions
Black Diamond Therapeutics Inc 61.23%$ 61.229 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com